These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20175797)

  • 1. Medication information for Flemish inpatients with major depression: evaluation and construct validity of the Consumer Information Rating Form.
    Desplenter F; Laekeman G; Demyttenaere K; ; Simoens S
    J Clin Pharm Ther; 2009 Dec; 34(6):645-55. PubMed ID: 20175797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of written medicine information: validation of the Consumer Information Rating Form.
    Koo MM; Krass I; Aslani P
    Ann Pharmacother; 2007 Jun; 41(6):951-6. PubMed ID: 17488832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and psychometric validation for evaluating written medicine information in Thailand: The Consumer Information Rating Form.
    Wongtaweepkij K; Krska J; Pongwecharak J; Pongpunna S; Jarernsiripornkul N
    BMJ Open; 2021 Oct; 11(10):e053740. PubMed ID: 34598992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies.
    Papakostas GI; Stahl SM; Krishen A; Seifert CA; Tucker VL; Goodale EP; Fava M
    J Clin Psychiatry; 2008 Aug; 69(8):1287-92. PubMed ID: 18605812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor analysis of electroacupuncture and selective serotonin reuptake inhibitors for major depressive disorder: an 8-week controlled clinical trial.
    Yang X; Gong W; Ma X; Wang S; Wang X; Guo T; Guo Z; Sun Y; Li J; Zhao B; Tu Y
    Acupunct Med; 2020 Feb; 38(1):45-52. PubMed ID: 31544488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors.
    Sheehan DV; Mancini M; Wang J; Berggren L; Cao H; Dueñas HJ; Yue L
    Hum Psychopharmacol; 2016 Jan; 31(1):53-63. PubMed ID: 26331440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
    Mallick R; Chen J; Entsuah AR; Schatzberg AF
    J Clin Psychiatry; 2003 Mar; 64(3):321-30. PubMed ID: 12716275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
    Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
    Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine or a second SSRI: Switching after treatment failure with an SSRI among depressed inpatients: a retrospective analysis.
    Barak Y; Swartz M; Baruch Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1744-7. PubMed ID: 21722691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
    Entsuah AR; Huang H; Thase ME
    J Clin Psychiatry; 2001 Nov; 62(11):869-77. PubMed ID: 11775046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials.
    Papakostas GI; Trivedi MH; Alpert JE; Seifert CA; Krishen A; Goodale EP; Tucker VL
    J Psychiatr Res; 2008 Jan; 42(2):134-40. PubMed ID: 17631898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using alternative methodologies for evaluating patient medication leaflets.
    Krass I; Svarstad BL; Bultman D
    Patient Educ Couns; 2002 May; 47(1):29-35. PubMed ID: 12023098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.
    Papakostas GI; Nutt DJ; Hallett LA; Tucker VL; Krishen A; Fava M
    Biol Psychiatry; 2006 Dec; 60(12):1350-5. PubMed ID: 16934768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter gene influences the time course of improvement of "core" depressive and somatic anxiety symptoms during treatment with SSRIs for recurrent mood disorders.
    Serretti A; Mandelli L; Lorenzi C; Pirovano A; Olgiati P; Colombo C; Smeraldi E
    Psychiatry Res; 2007 Jan; 149(1-3):185-93. PubMed ID: 17157919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of selective serotonin reuptake inhibitors (SSRI) in treating major depressive disorder: a protocol for network meta-analysis of randomised controlled trials.
    Jia Y; Zhu H; Leung SW
    BMJ Open; 2016 Jun; 6(6):e010142. PubMed ID: 27267106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.